Inventor · disambiguated record
Alex Nisthal
Also filed as: Nisthal Alex
19 granted patents·10 pending applications·44 citations·filing 2016–2025
91Inventor score
Top patents by PatentIndex Score
29 records- 0197US11472890B2Heterodimeric antibodies that bind ENPP3 and CD3XENCOR INC·Filed 2020·Granted Oct 18, 2022·9 cites·4 claims
- 0297US10787518B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2017·Granted Sep 29, 2020·15 cites·19 claims
- 0395US11919956B2Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3XENCOR INC·Filed 2021·Granted Mar 5, 2024·4 cites·8 claims
- 0494US10982006B2Heterodimeric antibodies that bind fibroblast activation proteinXENCOR INC·Filed 2019·Granted Apr 20, 2021·8 cites·23 claims
- 0592US12398207B2Heterodimeric antibodies that bind CD3 and CLDN6XENCOR INC·Filed 2024·Granted Aug 26, 2025·1 cites·4 claims
- 0690US11618776B2Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domainsXENCOR INC·Filed 2019·Granted Apr 4, 2023·4 cites·7 claims
- 0788US11739145B2Bispecific binding agents binding to CLDN18.2 and CD3ASTELLAS PHARMA EUROPE BV·Filed 2022·Granted Aug 29, 2023·1 cites·22 claims
- 0885US2025333519A1Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2025·Application pending·0 cites
- 0984US11236170B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2019·Granted Feb 1, 2022·1 cites·5 claims
- 1083US12378313B2Bispecific binding agents binding to CLDN18.2 and CD3XENCOR INC·Filed 2023·Granted Aug 5, 2025·0 cites·33 claims
- 1181US12404329B2Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3XENCOR INC·Filed 2024·Granted Sep 2, 2025·0 cites·6 claims
- 1281US2023041377A1Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2022·Application pending·0 cites
- 1379US11312770B2Bispecific and monospecific antibodies using novel anti-PD-1 sequencesXENCOR INC·Filed 2018·Granted Apr 26, 2022·1 cites·4 claims
- 1477US12448423B2Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domainsXENCOR INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 1577US2024228608A9Heterodimeric antibodies that bind cd3 and cldn6XENCOR INC·Filed 2023·Application pending·0 cites
- 1676US11739144B2Heterodimeric antibodies that bind CD3 and CLDN6XENCOR INC·Filed 2022·Granted Aug 29, 2023·0 cites·5 claims
- 1773US11859012B2Heterodimeric antibodies that bind CD3 and GPC3XENCOR INC·Filed 2022·Granted Jan 2, 2024·0 cites·5 claims
- 1873US11492407B2Bispecific checkpoint inhibitor antibodiesXENCOR INC·Filed 2019·Granted Nov 8, 2022·0 cites·6 claims
- 1972US2024034815A1Heterodimeric antibodies that bind cd3 and gpc3XENCOR INC·Filed 2023·Application pending·0 cites
- 2069US12152076B2Bispecific and monospecific antibodies using novel anti-PD-1 sequencesXENCOR INC·Filed 2022·Granted Nov 26, 2024·0 cites·11 claims
- 2167US2025084186A1Anti-cd28 x anti-enpp3 antibodiesXENCOR INC·Filed 2024·Application pending·0 cites
- 2266US2024166705A1Il18-fc fusion proteinsXENCOR INC·Filed 2023·Application pending·0 cites
- 2365US12180302B2Heterodimeric antibodies that bind fibroblast activation proteinXENCOR INC·Filed 2021·Granted Dec 31, 2024·0 cites·10 claims
- 2461US2023146665A1Il-18-fc fusion proteinsXENCOR INC·Filed 2022·Application pending·0 cites
- 2561US2024247062A1Heterodimeric antibodies that bind claudin18.2 and cd3XENCOR INC·Filed 2022·Application pending·0 cites
- 2659US2024360233A1Anti-tslpr (crlf2) antibodiesUNIV TEXAS·Filed 2022·Application pending·0 cites
- 2757US2022144956A1HETERODIMERIC ANTIBODIES THAT BIND TGFbetaRIIXENCOR INC·Filed 2021·Application pending·0 cites
- 2853US12006345B2Untargeted and targeted IL-10 Fc-fusion proteinsXENCOR INC·Filed 2020·Granted Jun 11, 2024·0 cites·13 claims
- 2946US9896700B2Engineered recombinant enzymes for methane oxidationUNIV NORTHWESTERN·Filed 2016·Granted Feb 20, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Alex Nisthal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →